CADL — Candel Therapeutics, Inc. | XLV Holdings | StockAdder

(CADL)

Candel Therapeutics, Inc.

Live chart and latest CADL stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

CADL News

Loss-Making Candel Therapeutics, Inc. (NASDAQ:CADL) Expected To Breakeven In The Medium-Term

Jan 14, 2026 Stock Titan

Director at Candel Therapeutics (NASDAQ: CADL) gets 2,795 options

Apr 2, 2026 Investing.com

Candel Therapeutics stock falls on $100 million offering pricing

Feb 20, 2026 simplywall.st

Breakeven On The Horizon For Candel Therapeutics, Inc. (NASDAQ:CADL)

Jan 17, 2026 GlobeNewswire

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 2, 2026 RTTNews

Is Candel Therapeutics On The Move With Pipeline Progress And Market Momentum?

Dec 12, 2025 Stock Titan

Candel gives five new hires options for 70,000 shares at $4.90

Apr 2, 2026 simplywall.st

Insider Purchases Worth US$3.00m See Losses As Candel Therapeutics Market Value Drops To US$352m

Mar 31, 2026 GlobeNewswire

Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Mar 12, 2026 Stock Titan

Candel Therapeutics (CADL) director granted 4,618 fully vested stock options

Apr 2, 2026 Stock Titan

Cancer biotech Candel prices $100M sale to back prostate launch prep, lung trial

Feb 19, 2026 Stock Titan

Candel Therapeutics (CADL) director granted fully vested stock options in lieu of cash fees

Apr 2, 2026 Stock Titan

Paul Manning holds 7.9% of Candel Therapeutics (NASDAQ: CADL) shares

Mar 18, 2026 Stock Titan

Cancer-drug maker Candel plans $100M sale for prostate, lung push

Feb 19, 2026 Stock Titan

Half of lung cancer patients alive 2 years in Candel immunotherapy study